RE:RE:RE:RE:Small correction to tableAgree Eoganacht, I made this same observation back in April when it appeared the FDA moved the goal post on TLT. The plan was to apply for BTD end of the 4th Q when they would have the needed stats. All of a sudden that plan was taken down. Why? It appeared the FDA had changed something.. The FDA has made dual approvals before in the case of immediate need, like the current need for a safe effective treatment for NMIBC. I don't remember what the exact ground rules were for that big move were but as I remember it was close to 100% safety and a high CR%. If that is the case, TLT is now close.It has happened before in a similar situation, so your suggestion is possible.